ArticleExperimental hematology & oncology2025

Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways.

Bailin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.